Drug safety in Canada

Throughout the cancer journey, survivors and patients come across a variety of different medications, drugs and medical devices. Therefore, it is very important that patients, survivors and caregivers are able to have confidence in the effectiveness of the drugs/devices that they are using, as well as be informed of any possible risks or dangers. Below are some resources that can be used in order to learn more about drug safety in Canada.

Canadian Patient Safety Institute

Established by Health Canada in 2003, the Canadian Patient Safety Institute (CPSI) works with governments, health organizations, leaders, and healthcare providers to inspire extraordinary improvement in patient safety and quality.

Canadian Pharmacogenomics Network for Drug Safety

The Canadian Pharmacogenomics Network for Drug Safety (CPNDS) is an innovative, national program that aims to reduce serious adverse drug reactions (ADRs) in children.

Drugs and Health Products – Health Canada

Health Canada plays an active role in ensuring that you have access to safe and effective drugs and health products. The Department strives to maintain a balance between the potential health benefits and risks posed by all drugs and health products. Our highest priority in determining the balance is public safety.

Drug Dangers

Our goal at Drug Dangers is to keep the public educated and informed of all defective medical devices and dangerous medications that are currently on the market. As an online resource sponsored by Seeger Weiss LLP, Drug Dangers strives to provide accurate, relevant medical information all in one place. Under the unfortunate circumstance that you or a loved one has been injured by faulty medications or devices, the attorneys of Seeger Weiss are committed to helping you receive the justice you deserve.

Drug Safety and Effectiveness Network

In Canada and worldwide, there are gaps in information on the safety and effectiveness of drugs used in real-world settings. More information is needed on the safety and effectiveness of pharmaceuticals when used by diverse patient populations outside the controlled experimental environment of clinical trials.

Medical Devices Bureau (MDB)

Information regarding: Medical Devices Premarket review, Medical Devices Standards, Information regarding device recalls.